Nasal Oral Articles & Analysis
7 news found
Rhinitis is chronic (CR) when symptoms of nasal obstruction, sneezing, itchy nose, and rhinorrhea persist for more than 3 months each year. ...
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective ...
ByFluidda
Oral surgery technically refers to any operation taking place on a person’s gums, teeth, or their surrounding oral spaces. ...
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
GALWAY, Ireland–(BUSINESS WIRE)–Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B financing. ...
Rhodes played a key role in the development of various commercial products and led translational research on delivery systems, including nasal, pulmonary and oral administration, as well as transdermal microporation technologies. ...